This kind of scares me as my problem started with overuse of visine. I know it's different and I would honestly probably use it if it was approved but not chronically as I did with the visine..
Any ideas when they plan for it to be out??
Announcement
Collapse
No announcement yet.
new redness reducing eye drops with no rebound!
Collapse
This topic is closed.
X
X
-
Originally posted by spmcc View PostThe active ingredient is brimonidine. Brimonidine is a vasoconstrictor. It's already available in a glaucoma eyedrop called Alphagan-P. The difference with these new B&L drops is they say it's "low dose brimonidine".
http://www.revophth.com/content/d/th...opics/c/35994/
this article claims that while it is a vasoconstrictor , it doesn't lose its effectiveness with daily use and doesn't have rebound. I wonder if it is too good to be true. they do say they are repurposing a glaucoma drug for eye whitening.
Leave a comment:
-
The active ingredient is brimonidine. Brimonidine is a vasoconstrictor. It's already available in a glaucoma eyedrop called Alphagan-P. The difference with these new B&L drops is they say it's "low dose brimonidine".
Leave a comment:
-
new redness reducing eye drops with no rebound!
hi all,
has anyone heard of this? http://visionplusmag.fourplusmedia.com/?p=1134
there are new eye drops that reduce redness with no rebound. I think they just passed phase two and has been licensed to baucsh and Lomb.
there are several articles about this if you google ...ocular redness bausch Lomb...
http://www.revophth.com/content/d/ne...vents/c/40162/
you can also check out this...
http://www.linkedin.com/in/ophthalmo...ent?_mSplash=1
while there may never be a cure for red eye sufferers, this may be as close as we can get to living normal lives again.
if anyone knows anything about clinical trials, I'd love your opinion on when this might hit the market. I know drugs for cancer and such could take years or decades but this would seem like a simple straight forward phase three trial and then FDA approval.
Leave a comment: